Section 8.4 - Register entry
DOC-REF: FRC-MKT-FR2616639378
Advantage eClinical
Veridix, LLC lists Advantage eClinical on the FedRAMP Marketplace with the status Agency Authorization In Process, at Moderate impact, on the Agency path under the Rev5 process. Package FR2616639378, read from the marketplace feed as of September 3, 2026.
Section A. Register entry
What the marketplace records
- FedRAMP package ID
- FR2616639378
- Cloud service provider
- Veridix, LLC
- Certification status
- Agency Authorization In Process
- Impact level
- Moderate
- Certification class
- Class C (Moderate)
- Authorization path
- Agency
- Certification type
- Rev5
- Marketplace phase
- Initial Implementation
- Deployment model
- Public Cloud
- Register snapshot
- September 3, 2026
- Service model
- SaaS
- Independent assessor
- Linford & Company
- Status date
- August 20, 2026
- FedRAMP Ready date
- May 13, 2026
- Business categories
- Analytics, Data Management, Research
- Milestones on record
- 2
The marketplace carries Advantage eClinical under package FR2616639378 with 16 recorded fields. Its current status was set on August 20, 2026, and a FedRAMP Ready date of May 13, 2026. Linford & Company is named as the independent assessor. No agency authorizations are listed against it in the current feed. It is delivered as SaaS on a public cloud, filed under 3 business categories including Analytics, Data Management and Research.
Section B. Milestones
2 entries in the marketplace event log
Most recent first, as recorded by FedRAMP.
| Date | Category | Recorded |
|---|---|---|
| August 20, 2026 | Status Change | Status changed from FedRAMP Ready to Agency Authorization In Process |
| May 13, 2026 | Status Change | Status set to Legacy FedRAMP Ready |
Section C. Cost context
What reaching Moderate costs
Our own published ranges for a provider going through this level. Nothing here is a figure this provider has disclosed.
Cost context
Budget for a Moderate authorization
Our published planning range for a provider pursuing Moderate. It is not a figure any listed provider has disclosed.
Read the FedRAMP Moderate cost guide / annual assessment cost / continuous monitoring cost
Path
Agency Authorization is the route for 578 of the offerings on the marketplace. Our cost pages put it at $800,000 to $2,000,000 over 12 to 18 months for Moderate. Agency authorization cost
Assessment and monitoring
No annual assessment date is on the record. Assessment recurs annually for as long as a package stays listed. Annual assessment cost / continuous monitoring cost
Section G. Nearest entries on the register
Comparable offerings
Scored on impact level, path, status, shared business categories and how close the two entries sit in the register's own timeline.
- Patlytics AI Platform
Patlytics, Inc.
Agency Authorization In Process, Moderate impact, Agency path, Rev5.
- Verily Pre
Verily Health
Agency Authorization In Process, Moderate impact, Agency path, Rev5.
- Supply Chain Command
BlueVoyant Government Services
Agency Authorization In Process, Moderate impact, Agency path, Rev5.
- Lifebit Platform
Lifebit Biotech
Agency Authorization In Process, Moderate impact, Agency path, Rev5.
- LexisNexis Risk Enterprise Platform
LexisNexis Risk Solutions
Agency Authorization In Process, Moderate impact, Agency path, Rev5.
Section H. Description
As published on the marketplace
The provider's own description of the service, reproduced from the FedRAMP feed without edits.
Veridix' Advantage eClinical® is an integrated collection of web-enabled application subsystems and utilities specifically designed, configured, and deployed to ensure secure data entry and to satisfy the reporting needs of the clinical trials and research studies.
Next step
What the same authorization would cost you
The worksheet turns an impact level, an existing security posture and an organization size into a line-by-line budget, with the 3PAO fee split out.
Provenance and independence
Source: the FedRAMP Marketplace product feed, produced by the General Services Administration. The feed's own last-change stamp is September 3, 2026; this copy was taken on September 5, 2026.
GSA's disclaimers page states that FedRAMP content about a specific commercial product or service is provided for the information and convenience of the public and “does not constitute endorsement, recommendation, or favoring by the General Services Administration”. A listing here is a record of a certification status, not a judgment about the product.
FedRAMPCost.com is an independent cost reference. We are not affiliated with FedRAMP, the GSA, any provider listed on this page, or any assessment organization, and no provider pays to appear in this register.